Evolus 8-K Details Operations & Financial Condition
Ticker: EOLS · Form: 8-K · Filed: Jan 16, 2024 · CIK: 1570562
| Field | Detail |
|---|---|
| Company | Evolus, INC. (EOLS) |
| Form Type | 8-K |
| Filed Date | Jan 16, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: financial-condition, results-of-operations, 8-K, corporate-update
TL;DR
**Evolus just dropped an 8-K on its financials, signaling an update on company performance.**
AI Summary
Evolus, Inc. filed an 8-K on January 16, 2024, reporting on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits.' This filing indicates that the company is providing an update on its financial performance, which is crucial for investors to understand the company's current health and future prospects. For shareholders, this matters because it offers transparency into how the company is performing, directly influencing stock valuation and investment decisions.
Why It Matters
This filing provides an update on Evolus's financial health, which is essential for investors to assess the company's performance and make informed decisions about buying, holding, or selling its stock.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial information, not indicating any immediate new risks or significant changes.
Analyst Insight
Investors should look for the actual financial results and statements that will be attached to this 8-K to understand the specifics of Evolus's performance and any forward-looking guidance.
Key Players & Entities
- Evolus, Inc. (company) — the registrant filing the 8-K
- January 16, 2024 (date) — date of earliest event reported and filing date
- 001-38381 (other) — Commission File Number for Evolus, Inc.
- EOLS (other) — trading symbol for Evolus, Inc. Common Stock
- The Nasdaq Stock Market LLC (Nasdaq Global Market) (other) — exchange where Evolus, Inc. Common Stock is registered
FAQ
What is the purpose of this 8-K filing by Evolus, Inc.?
The purpose of this 8-K filing, dated January 16, 2024, is to report on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' as per Item 2.02 and Item 9.01 of Form 8-K.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing was January 16, 2024.
What is the trading symbol and exchange for Evolus, Inc.'s common stock?
Evolus, Inc.'s common stock has the trading symbol EOLS and is registered on The Nasdaq Stock Market LLC (Nasdaq Global Market).
Where is Evolus, Inc.'s principal executive office located?
Evolus, Inc.'s principal executive office is located at 520 Newport Center Drive, Suite 1200, Newport Beach, California 92660.
What is Evolus, Inc.'s Commission File Number?
Evolus, Inc.'s Commission File Number, as specified in the filing, is 001-38381.
Filing Stats: 539 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-01-16 17:28:48
Key Financial Figures
- $0.00001 — ich registered Common Stock, par value $0.00001 per share EOLS The Nasdaq Stock Market
Filing Documents
- eols-20240116.htm (8-K) — 25KB
- ex991012024.htm (EX-99.1) — 35KB
- imagea.jpg (GRAPHIC) — 10KB
- 0001570562-24-000003.txt ( ) — 204KB
- eols-20240116.xsd (EX-101.SCH) — 2KB
- eols-20240116_lab.xml (EX-101.LAB) — 23KB
- eols-20240116_pre.xml (EX-101.PRE) — 12KB
- eols-20240116_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 16, 2024, the Company issued a press release announcing its preliminary, unaudited net revenue and certain other operational and financial data for the quarter and year ended December 31, 2023. The press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release of Evolus, Inc., dated January 16, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Evolus, Inc. Dated: January 16, 2024 /s/ David Moatazedi David Moatazedi President and Chief Executive Officer